EICOSANOID MEDIATED PRESSOR MECHANIMS IN HYPERTENSION
EICOSANOID MEDIATED PRESSOR MECHANIMS IN HYPERTENSION
批准号:
6202239
负责人:
ALBERTO NASJLETTI
金额:
$24.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-20 至 2000-08-31
关键词:
angiotensin /renin /aldosterone hypertension antihypertensive agents arachidonate cytochrome P450 disease /disorder model eicosanoids enzyme activity enzyme inhibitors fatty acid metabolism gas chromatography mass spectrometry glucocorticoids hemodynamics hormone regulation /control mechanism isolation perfusion kidney function laboratory rat lipoxygenase nonhuman therapy evaluation prostacyclins prostaglandins spontaneous hypertensive rat vasoconstriction
中文摘要
这是一个研究机制和对血压的影响的建议
调节类花生酸介导的升压和
正常血压和高血压大鼠的血管降压功能。研究是
在两个相关领域提出。
区域1:血管对花生四烯酸代谢的影响
脂氧合酶在前列腺素介导的血压机制中的作用
监管-要测试的假设是,过度形成的
脂氧合酶产物,可能是花生四烯酸氢过氧化物,
血管紧张素依赖性高血压大鼠的动脉血管
有助于通过促进表达的血压升高
PGH 2介导的血管收缩机制,并通过限制
PGI 2介导的血管舒张机制的活性。实验将
在血管紧张素依赖性高血压(主动脉)大鼠中进行
血管紧张素II输注诱导的高血压
高血压),在大鼠血管紧张素非依赖性高血压(DOCA-
盐诱导的高血压)和相应的血压正常对照。
在这些实验模型中,我们提出实验(a)以识别
并定量血压正常和正常人血管组织中的脂氧合酶活性,
(B)检查脂氧合酶与高血压大鼠的关系,
正常血压血管组织的产物形成和PGI_2产生
和高血压大鼠;(c)研究
脂氧合酶产物与高血压机制的关系
脂氧合酶抑制对血压的影响及相关
高血压和正常血压大鼠的肾功能;(d)探索
抑制脂氧合酶的血流动力学反应与
和PGI 2介导的血管降压系统的活性;(e)检查
脂氧合酶产物形成与表达的关系
PGH 2介导的小动脉血管收缩机制
血压正常和高血压大鼠的血压。
区域2:细胞色素P450对花生四烯酸代谢的影响
加氧酶对正常血压和高血压大鼠血压的影响
待检验的假设是2 O-HETE有助于增加血液
压力和血管反应性在年轻的SHR和其他模型,
20-HETE合成过度表达的高血压。实验
将在SHR中进行,在通过用
DOCA-盐或地塞米松,以及相应的血压正常
对照在这些模型中,我们提出实验(a)来研究
用20-HETE合成抑制剂治疗对全身性
正常血压大鼠、自发性高血压大鼠和高血压大鼠的血流动力学和相关肾功能
其他形式的实验性高血压;(B)探索20-
HETE在调节血管对收缩激素反应性中的作用
正常血压和高血压大鼠。
英文摘要
This is a proposal to study the mechanisms and impact on blood pressure
regulation of relationships between eicosanoid-mediated pressor and
vasodepressor functions in normotensive and hypertensive rats. Research is
proposed in two related areas.
AREA l: The Influence of Arachidonic Acid Metabolism by Vascular
Lipoxygenase(s) on Prostanoid-Mediated Mechanisms of Blood Pressure
Regulation - The hypothesis to be tested is that excessive formation of
lipoxygenase products, presumably arachidonic acid hydroperoxides, by the
arterial vessels of rats with angiotensin-dependent hypertension
contributes to the elevation of blood pressure by fostering the expression
of a vasoconstrictor mechanism mediated by PGH2 and by limiting the
activity of a vasodilatory mechanism mediated by PGI2. Experiments will be
conducted in rats with angiotensin-dependent hypertension (aortic
coarctation-induced hypertension; angiotensin II-infusion-induced
hypertension), in rats with angiotensin-independent hypertension (DOCA-
salt-induced hypertension) and in the corresponding normotensive controls.
In these experimental models we propose experimentation (a) to identify
and quantify lipoxygenase activity in vascular tissues of normotensive and
hypertensive rats; (b)to examine the relationship between lipoxygenase(s)
product formation and PGI2 production by vascular tissues of normotensive
and hypertensive rats; (c) to investigate the contribution of
lipoxygenase(s) products to mechanisms of hypertension by determining the
consequences of lipoxygenase(s) inhibition on blood pressure and relevant
renal functions of hypertensive and normotensive rats; (d) to explore
relationships between the hemodynamic response to lipoxygenase inhibition
and the activity of vasodepressor systems mediated by PGI2; (e) to examine
the relationship between lipoxygenase product formation and the expression
of PGH2-mediated mechanism of vasoconstriction in small arterial vessels
of normotensive and hypertensive rats.
AREA 2: The Influence of Arachidonic Acid Metabolism by Cytochrome P450
Oxygenases on the Blood Pressure of Normotensive and Hypertensive Rats -
The hypothesis to be tested is that 2O-HETE contributes to increase blood
pressure and vascular reactivity in young SHR and in other models of
hypertension in which 20-HETE synthesis is hyperexpressed. Experiments
will be conducted in SHR, in rats made hypertensive by treatment with
DOCA-salt or with dexamethasone, and in the corresponding normotensive
controls. In these models we propose experimentation (a) to investigate
the effect of treatment with an inhibitor of 20-HETE synthesis on systemic
hemodynamics and relevant renal functions in normotensive rats, SHR and
other forms of experimental hypertension; (b)to explore the role of 20-
HETE in regulation of vascular responsiveness to constrictor hormones in
normotensive and hypertensive rats.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administration
-
批准号:7137845
-
项目类别:
-
资助金额:$30.77万
-
财政年份:2005
-
负责人:ALBERTO NASJLETTI
-
依托单位:
Vasoregulatory Function of CYP2E1-Derived Eicosanoids
-
批准号:7137823
-
项目类别:
-
资助金额:$44.19万
-
财政年份:2005
-
负责人:ALBERTO NASJLETTI
-
依托单位:
FUNCTIONAL SIGNIFICANCE: CYTOCHROME P450/HEME OXYGENASE
-
批准号:6796313
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2003
-
负责人:ALBERTO NASJLETTI
-
依托单位:
FUNCTIONAL SIGNIFICANCE: CYTOCHROME P450/HEME OXYGENASE
-
批准号:6653342
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2002
-
负责人:ALBERTO NASJLETTI
-
依托单位:
FUNCTIONAL SIGNIFICANCE: CYTOCHROME P450/HEME OXYGENASE
-
批准号:6500477
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2001
-
负责人:ALBERTO NASJLETTI
-
依托单位:
FUNCTIONAL SIGNIFICANCE: CYTOCHROME P450/HEME OXYGENASE
-
批准号:6578853
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2001
-
负责人:ALBERTO NASJLETTI
-
依托单位:
FUNCTIONAL SIGNIFICANCE: CYTOCHROME P450/HEME OXYGENASE
-
批准号:6353522
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2000
-
负责人:ALBERTO NASJLETTI
-
依托单位:
EICOSANOID MEDIATED PRESSOR MECHANIMS IN HYPERTENSION
-
批准号:6109760
-
项目类别:
-
资助金额:$24.35万
-
财政年份:1998
-
负责人:ALBERTO NASJLETTI
-
依托单位:
EICOSANOID MEDIATED PRESSOR MECHANIMS IN HYPERTENSION
-
批准号:6241860
-
项目类别:
-
资助金额:$23.54万
-
财政年份:1997
-
负责人:ALBERTO NASJLETTI
-
依托单位:
Hormonal Regulation of Blood Pressure
-
批准号:6962139
-
项目类别:
-
资助金额:$234.82万
-
财政年份:1997
-
负责人:ALBERTO NASJLETTI
-
依托单位:
Hormonal Regulation of Blood Pressure
-
批准号:7110954
-
项目类别:
-
资助金额:$234.63万
-
财政年份:1997
-
负责人:ALBERTO NASJLETTI
-
依托单位:
Hormonal Regulation of Blood Pressure
-
批准号:7280406
-
项目类别:
-
资助金额:$233.87万
-
财政年份:1997
-
负责人:ALBERTO NASJLETTI
-
依托单位:
GORDON RESEARCH CONFERENCE ON KALLIKREINS & KININS
-
批准号:3435658
-
项目类别:
-
资助金额:$1.83万
-
财政年份:1989
-
负责人:ALBERTO NASJLETTI
-
依托单位:
VASOACTIVE HORMONES AND BLOOD PRESSURE REGULATION
-
批准号:2215148
-
项目类别:
-
资助金额:$32.62万
-
财政年份:1987
-
负责人:ALBERTO NASJLETTI
-
依托单位:
VASOACTIVE HORMONES AND BLOOD PRESSURE REGULATION
-
批准号:3335614
-
项目类别:
-
资助金额:$17.45万
-
财政年份:1987
-
负责人:ALBERTO NASJLETTI
-
依托单位:
VASOACTIVE HORMONES AND BLOOD PRESSURE REGULATION
-
批准号:3565424
-
项目类别:
-
资助金额:$27.6万
-
财政年份:1987
-
负责人:ALBERTO NASJLETTI
-
依托单位:
VASOACTIVE HORMONES AND BLOOD PRESSURE REGULATION
-
批准号:3485569
-
项目类别:
-
资助金额:$26.91万
-
财政年份:1987
-
负责人:ALBERTO NASJLETTI
-
依托单位:
VASOACTIVE HORMONES AND BLOOD PRESSURE REGULATION
-
批准号:2445089
-
项目类别:
-
资助金额:$33.52万
-
财政年份:1987
-
负责人:ALBERTO NASJLETTI
-
依托单位:
ROLE OF PRESSOR PROSTANOIDS IN HYPERTENSION
-
批准号:3351810
-
项目类别:
-
资助金额:$15.38万
-
财政年份:1987
-
负责人:ALBERTO NASJLETTI
-
依托单位:
ROLE OF PRESSOR PROSTANOIDS IN HYPERTENSION
-
批准号:3351814
-
项目类别:
-
资助金额:$18.72万
-
财政年份:1987
-
负责人:ALBERTO NASJLETTI
-
依托单位:
海外基金